Pele Dina, MD

Assistant Professor of Clinical Pediatrics - Neonatology

    About me

    Dr. Pele Dina is an assistant professor of clinical pediatrics at SIU School of Medicine, specializing in neonatal-perinatal medicine. He completed a doctor of medicine degree at the University of Balamand, in Balamand, Lebanon. He completed pediatric residencies at Saint George Hospital University Medical Center, in Beirut, Lebanon and at St. John's Children's Hospital, in Springfield, Illinois. He completed a fellowship in neonatal-perinatal medicine at Ronald McDonald's Children's Hospital, in Maywood, Illinois. His research efforts include the analgesic effect of breast milk compared to oral sucrose solution on preterm neonates undergoing minor painful procedures, and what makes us evaluate infants for sepsis in the NICU. Dr. Dina is board certified in pediatrics.



    Additional languages spoken


    Education & training

    Board Certifications
    Medical School
    Univeristy of Balamand, Balamand, Lebanon
    Undergraduate Degree
    University of Balamand, Balamand, Lebanon
    Saint George Hospital University Medical Center, Beirut, Lebanon - General Pediatrics
    St. John’s Children’s Hospital, Springfield, Illinois - General Pediatrics
    Ronald McDonald’s Children’s Hospital, Maywood, Illinois - Neonatal-Perinatal Medicine


    • Abstract of Excellence - Poster presentation of “Improving antibiotics and Intravenous(IV) dextrose administration timing in neonates after admission to the neonatal ICU” with Dr. Lawrence Bennett, Illinois Perinatal Quality Collaborative 4th Annual Conference, Lombard, Illinois                                                                                                                 
    • MAGIS Star (Multiple), Ronald McDonald’s Children’s Hospital, Maywood, Illinois
    • Outstanding Service Award, Loyola University Medical Center - Recognition from Neonatal ICU nursing staff and/or Doctors from providing outstanding service/care.

    Clinical trials


    A Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing Enterocolitis - The Connection Study

    Active recruiting

    The purpose of the clinical study is to compare the effectiveness of IBP-9414 treatment against placebo in preventing necrotizing enterocolitis in premature infants.


    Treatments: Prevention of necrotizing enterocolitis in premature infants